Pages that link to "Q57412871"
Jump to navigation
Jump to search
The following pages link to Risk of Cardiac Arrhythmias During Hypoglycemia in Patients With Type 2 Diabetes and Cardiovascular Risk (Q57412871):
Displaying 50 items.
- Universal structures of normal and pathological heart rate variability (Q27345101) (← links)
- Risk Factors and Adverse Outcomes of Severe Hypoglycemia in Type 2 Diabetes Mellitus (Q28072980) (← links)
- Increasing the use of biocompatible, glucose-free peritoneal dialysis solutions (Q28082263) (← links)
- Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes (Q30491380) (← links)
- The Impact of Insulin Pump Therapy on Glycemic Profiles in Patients with Type 2 Diabetes: Data from the OpT2mise Study (Q30985130) (← links)
- Prevalence of and risk factors for hypoglycemic symptoms after gastric bypass and sleeve gastrectomy (Q33165603) (← links)
- Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group. (Q33790423) (← links)
- Prediction of nocturnal hypoglycemia unawareness by fasting glucose levels or post-breakfast glucose fluctuations in patients with type 1 diabetes receiving insulin degludec: A pilot study (Q33879458) (← links)
- α-Glucosidase inhibitor miglitol attenuates glucose fluctuation, heart rate variability and sympathetic activity in patients with type 2 diabetes and acute coronary syndrome: a multicenter randomized controlled (MACS) study (Q33883808) (← links)
- We can change the natural history of type 2 diabetes (Q34219402) (← links)
- Glycemic variability and oxidative stress: a link between diabetes and cardiovascular disease? (Q34486820) (← links)
- Does glycemic control reverse dispersion of ventricular repolarization in type 2 diabetes? (Q34570576) (← links)
- Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on the Treatment and Prevention of Atrial Fibrillation, Washington, DC, December 9-10, 2013. (Q35585789) (← links)
- Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18,168 people with type 1 diabetes: observational study (Q35765550) (← links)
- Can Fasting Glucose Levels or Post-Breakfast Glucose Fluctuations Predict the Occurrence of Nocturnal Asymptomatic Hypoglycemia in Type 1 Diabetic Patients Receiving Basal-Bolus Insulin Therapy with Long-Acting Insulin? (Q35857134) (← links)
- Update on strategies limiting iatrogenic hypoglycemia (Q35881959) (← links)
- Association of silent hypoglycemia with cardiac events in non-diabetic subjects with acute myocardial infarction undergoing primary percutaneous coronary interventions (Q35998520) (← links)
- Effect of hypoxia on heart rate variability and baroreflex sensitivity during hypoglycemia in type 1 diabetes mellitus (Q36058927) (← links)
- Blood electrolyte disturbances during severe hypoglycemia in Korean patients with type 2 diabetes (Q36081194) (← links)
- Association of hypoglycemia with incident chronic kidney disease in patients with type 2 diabetes: a nationwide population-based study (Q36152043) (← links)
- Hypoglycaemia, Abnormal Lipids, and Cardiovascular Disease among Chinese with Type 2 Diabetes (Q36173012) (← links)
- Baroreflex Sensitivity Impairment During Hypoglycemia: Implications for Cardiovascular Control (Q36392868) (← links)
- Major adverse cardiovascular events with basal insulin peglispro versus comparator insulins in patients with type 1 or type 2 diabetes: a meta-analysis (Q36907339) (← links)
- Hypoglycemia-Associated Autonomic Failure in Diabetes: Maladaptive, Adaptive, or Both? (Q36926342) (← links)
- Risk of post-gastric bypass surgery hypoglycemia in nondiabetic individuals: A single center experience (Q37033642) (← links)
- Twice-daily insulin degludec/insulin aspart provides superior fasting plasma glucose control and a reduced rate of hypoglycaemia compared with biphasic insulin aspart 30 in insulin-naïve adults with Type 2 diabetes. (Q37337300) (← links)
- Even silent hypoglycemia induces cardiac arrhythmias (Q37715600) (← links)
- Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications (Q38257168) (← links)
- Avoiding or coping with severe hypoglycemia in patients with type 2 diabetes (Q38318796) (← links)
- Probing SGLT2 as a therapeutic target for diabetes: basic physiology and consequences. (Q38330456) (← links)
- Biomarkers associated with severe hypoglycaemia and death in ACCORD. (Q38371823) (← links)
- Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 1 Diabetes: The SWITCH 1 Randomized Clinical Trial (Q38374620) (← links)
- Identification of drug targets related to the induction of ventricular tachyarrhythmia through a systems chemical biology approach (Q38465804) (← links)
- Implantable cardioverter defibrillators in diabetics: efficacy and safety in patients at risk of sudden cardiac death (Q38534275) (← links)
- Hypoglycemia and Comorbidities in Type 2 Diabetes. (Q38580512) (← links)
- Recognizing and minimizing hypoglycemia: The need for individualized care (Q38584785) (← links)
- Interdisciplinary approach to compensation of hypoglycemia in diabetic patients with chronic heart failure. (Q38604382) (← links)
- Hypoglycemia and Cardiovascular Disease: Lessons from Outcome Studies (Q38607502) (← links)
- Comparative review of dipeptidyl peptidase-4 inhibitors and sulphonylureas. (Q38644587) (← links)
- Glycaemic outcomes of an Individualized treatMent aPproach for oldER vulnerable patIents: A randomized, controlled stUdy in type 2 diabetes Mellitus (IMPERIUM). (Q38663548) (← links)
- Increased mortality risk in diabetic patients discharged from hospital with insulin therapy after an acute myocardial infarction: Data from the FAST-MI 2005 registry. (Q38686913) (← links)
- Arrhythmia Vulnerability in Diabetic Cardiac Tissue is Species-Dependent: Effects of I KATP, Uncoupling, and Connexin Lateralization (Q38705779) (← links)
- Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia (Q38740284) (← links)
- Risk of Cardiovascular Events in Patients With Diabetes Mellitus on β-Blockers (Q38755607) (← links)
- The Emory University Perioperative Algorithm for the Management of Hyperglycemia and Diabetes in Non-cardiac Surgery Patients (Q38771951) (← links)
- Empagliflozin: Role in Treatment Options for Patients with Type 2 Diabetes Mellitus (Q39006105) (← links)
- Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trial (Q39036811) (← links)
- Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis. (Q39040207) (← links)
- Role of SGLT2 Inhibitors in Patients with Diabetes Mellitus and Heart Failure (Q39396845) (← links)
- Outcomes and healthcare resource utilization associated with medically attended hypoglycemia in older patients with type 2 diabetes initiating basal insulin in a US managed care setting (Q39770614) (← links)